3,630
Participants
Start Date
March 31, 2008
Primary Completion Date
January 31, 2010
Study Completion Date
January 31, 2010
Serogroup B meningococcal Vaccine lot 1 (rMenB Lot 1)
One dose of rMenB Lot concomitantly with the routinely administered infant vaccines
Serogroup B meningococcal Vaccine lot 2 (rMenB Lot 2)
One dose of rMenB concomitantly with the routinely administered infant vaccines
Serogroup B meningococcal Vaccine lot 3 (rMenB Lot 3)
One dose of rMenB concomitantly with the routinely administered infant vaccines
Infanrix Hexa
Routine vaccination
Menjugate
One dose of the routinely administered infant vaccines + MenC vaccine
Prevenar
Routine vaccination
Sommer, Vienna
Prieler, Neufeld A.d. Leitha
Häckel, Kirchdorf
Angermayr, Wels
Maurer, Salzburg
Grässl, Hall in Tirol
Site 47, Lahti
Site 5, Prague
Dipartimento di Scienze della Salute, Genova
Site 6, Prague
Fondazione IRCCS Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena Italia, Milan
Pediatria dell' Ospedale Sacco, Milan
Site 53, Turku
Site 50, Pori
Ospedale Maggiore della Carita'-Clinica Pediatrica, Novara
Site 92, Espelkamp
Site 81, Porta Westfalica
Site 99, Detmold
Site 52, Tampere
Site 64, Fulda
Site 45, Kotka
Site11, Červený Kostelec
Site 51, Seinäjoki
Site 35, Kokkola
Site 46, Kuopio
Site 65, Schwieberdingen
ASL/TA, Taranto
Site 58, Lauffen am Neckar
Site 57, Marbach A. N.
Site 97, München
Site 96, München
Site 91, Műnchen
Site 94, Weilheim
Site 95, Freising
Site 49, Oulu
Università degli Studi di Messina - Pad. NI - A.O.U. Policlinico G. Martino, Messina
Site 27, Boskovice
Site 19, Brno
Site 22, Chomutov
Site 14, Děčín
Site 12, Havlíčkův Brod
Site 8, Hradec Králové
Site 9, Hradec Králové
Site 28, Hranice I-mesto
Site 13, Humpolec
Site 15, Jindřichův Hradec
Site 25, Kladno
Site 21, Kolín
Site 10, Liberec
Site 24, Litoměřice
Site 17, Ostrava
Site 18, Ostrava-Poruba
Site 7, Pardubice
Site 16, Pilsen
Site 2, Prague
Site 3, Prague
Site 26, Rumburk
Site 23, Ústí nad Labem
Site 20, Znojmo
Site 30, Espoo
Site 31, Helsinki
Site 32, Helsinki
Site 34, Järvenpää
Site 33, Vantaa
Site 48, Vantaa
Istituto di Igiene e Medicina Preventiva - Università degli Studi di Sassari, Sassari
Lead Sponsor
Collaborators (1)
GlaxoSmithKline
INDUSTRY
Novartis Vaccines
INDUSTRY